GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Myriad Genetics Inc (HAM:MYD) » Definitions » Change In Prepaid Assets

Myriad Genetics (HAM:MYD) Change In Prepaid Assets : €3.1 Mil (TTM As of Mar. 2025)


View and export this data going back to 1995. Start your Free Trial

What is Myriad Genetics Change In Prepaid Assets?

Myriad Genetics's Change In Prepaid Assets for the quarter that ended in Mar. 2025 was €-0.1 Mil. It means Myriad Genetics's Prepaid Assets declined by €0.1 Mil from Dec. 2024 to Mar. 2025 .

Myriad Genetics's Change In Prepaid Assets for the fiscal year that ended in Dec. 2024 was €-3.1 Mil. It means Myriad Genetics's Prepaid Assets declined by €3.1 Mil from Dec. 2023 to Dec. 2024 .

Myriad Genetics Change In Prepaid Assets Historical Data

The historical data trend for Myriad Genetics's Change In Prepaid Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Myriad Genetics Change In Prepaid Assets Chart

Myriad Genetics Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Dec21 Dec22 Dec23 Dec24
Change In Prepaid Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.78 73.72 2.17 0.83 -3.06

Myriad Genetics Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Prepaid Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.07 2.88 -1.08 1.43 -0.09

Myriad Genetics Change In Prepaid Assets Calculation

Change In Prepaid Assets is any increase or decrease between periods of the prepaid assets.

Change In Prepaid Assets for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Myriad Genetics Change In Prepaid Assets Related Terms

Thank you for viewing the detailed overview of Myriad Genetics's Change In Prepaid Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Myriad Genetics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Myriad Genetics Inc (HAM:MYD) » Definitions » Change In Prepaid Assets
Comparable Companies
CSTL FLGT CDNA PSNL STIM ATLN OPK NEOG LDDD ACRS TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD NTRA WAT
Traded in Other Exchanges
MYGN:USA 0K3W:UK MYD:Germany
Address
322 North 2200 West, Salt Lake City, UT, USA, 84116
Website
https://www.myriad.com
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.